MEF2D and Parkinson disease: There is abundant evidence that promoting the expression of MEF2D is considered to have a neuroprotective effect in vivo and in vitro,33 and the down‐regulation of MEF2D shows negative effects, such as PC12 cell death,34 subarachnoid haemorrhage35 and Parkinson's disease.36